Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy

AIMS: Current thrombolytic therapies rely upon exogenous plasminogen activators (PA) to effectively lyse clots, thereby restoring blood flow and preventing tissue and organ death. Yet, these PAs may also impair normal hemostasis which may lead to life-threatening bleeding, including intracerebral he...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McCarthy, Jason R., Sazonova, Irina Y., Erdem, S. Sibel, Hara, Tetsuya, Thompson, Brian D., Patel, Purvish, Botnaru, Ion, Lin, Charles P., Reed, Guy L., Weissleder, Ralph, Jaffer, Farouc A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360120/
https://ncbi.nlm.nih.gov/pubmed/22348271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm.11.179
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados